BLOG / 🇺🇸 United States · · daily

High-Value Federal Grants ($5M+) — June 21, 2026

High-Value Federal Grants ($5M+)

By Gunpowder Editorial ·

2 total filings analysed

Executive Summary

The digest covers $3.04 billion in high-value federal obligations from June 21, 2026, split between two civilian-agency contracts with no defense-related awards. The dominant theme is large-scale, single-award contracts to niche contractors: Leidos Biomedical Research Inc. secured a $1.78B award from HHS, while Bollinger Shipyards Lockport won a $1.26B award from DHS.

Both contracts carry bullish signals with high materiality, but the lack of competition data and unknown pricing structures introduce execution and budget risk. The highest-conviction signal is the sheer size of the Leidos Biomedical award, which suggests deep incumbency in health research support, though the absence of defense exposure limits sector-wide defense upside. Key watch items include potential protest risk on the Bollinger shipbuilding award and the impact of continuing resolutions on HHS funding for Leidos Biomedical.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from June 20, 2026.

Investment Signals (2)

  • Leidos Biomedical Research Inc. wins $1.78B HHS contract, signaling durable incumbency (MEDIUM)

    Leidos Biomedical Research Inc. received a $1.78B award from the Department of Health and Human Services, the largest single contract in this digest. This suggests strong incumbency in biomedical research support services, though the lack of competition signal and pricing details warrants caution.

  • Bollinger Shipyards Lockport wins $1.26B DHS award, boosting shipbuilding backlog (MEDIUM)

    Bollinger Shipyards Lockport, L.L.C. secured a $1.26B contract from the Department of Homeland Security, likely for Coast Guard vessel construction or maintenance. This significantly expands the company's shipbuilding backlog and reinforces its position in the naval/coastal defense industrial base.

Risk Flags (3)

  • Execution [MEDIUM RISK]

    Both contracts lack pricing structure details (fixed-price vs. cost-plus), creating uncertainty about margin profiles and cost overrun exposure for Leidos Biomedical and Bollinger Shipyards.

  • Budget [MEDIUM RISK]

    The $1.78B HHS award to Leidos Biomedical is vulnerable to continuing resolution (CR) uncertainty if awarded during a CR period, potentially delaying funding or reducing scope.

  • Competition [MEDIUM RISK]

    The Bollinger Shipyards award may face protest from competitors, given the large single-award nature and lack of disclosed competition signal. Protests could delay revenue recognition.

Opportunities (2)

  • Bollinger Shipyards' $1.26B DHS award positions it for follow-on Coast Guard shipbuilding programs, potentially expanding into Navy small surface combatant work.

  • Leidos Biomedical's $1.78B HHS award reinforces the trend of large civilian health research contracts, opening opportunities for other health IT and research support firms like GDIT and CACI.

Sector Themes (1)

  • Both contracts in this digest are from civilian agencies (HHS and DHS) and total over $3B, indicating that large, single-award civilian contracts remain a significant growth driver for government services firms, even without defense exposure.

Watch List (2)

  • 👁

    {"entity"=>"Leidos Holdings Inc.", "reason"=>"Subsidiary Leidos Biomedical Research Inc. won the largest contract in this digest ($1.78B), which could materially impact parent company revenue if executed well.", "trigger"=>"Quarterly earnings report for backlog update, HHS budget appropriation, contract modification filings"}

  • 👁

    {"entity"=>"Bollinger Shipyards", "reason"=>"The $1.26B DHS award significantly boosts shipbuilding backlog, but execution risk and potential protest are key watch items.", "trigger"=>"GAO protest decision deadline, contract start date, quarterly earnings for revenue recognition"}

Get daily alerts with 2 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 2 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: High-Value Federal Grants ($5M+)

🇺🇸 More from United States

View all →